Clinical Trial Update: Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing the long-term effectiveness, safety, and tolerability of carisbamate to two other frequently prescribed anti-epileptic drugs in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Seizures

Drugs mentioned

• carisbamate (carisbamate)

Snippet

Sponsor: SK Life Science, Inc. | Conditions: Epilepsy, Seizures | Phase 3 | Status: TERMINATED